Journal
BRITISH JOURNAL OF PHARMACOLOGY
Volume 140, Issue 5, Pages 871-880Publisher
WILEY
DOI: 10.1038/sj.bjp.0705487
Keywords
Ca2+ sensitization; cerebral artery; thromboxane A(2); myosin light chain; myosin light chain kinase; Rho kinase
Categories
Ask authors/readers for more resources
1 The role of Rho kinase in Ca2+ sensitization of the contractile apparatus in smooth muscle was investigated in the bovine middle cerebral artery. 2 U46619, a thromboxane A(2) analog, induced a greater sustained contraction with a smaller [Ca2+](i) elevation than that seen with 118 mM K+. The level of myosin light chain (MLC) phosphorylation obtained in the initial phase of the contraction was higher than that seen with 118 mM K+; thereafter, it gradually declined to a comparable level in the late phase. 3 During the steady state of the U46619-induced contraction, Y27632 (10 muM), a Rho-kinase inhibitor, partially inhibited [Ca2+](i), although it substantially inhibited tension and MLC phosphorylation. Wortmannin (10 mM), an MLC kinase inhibitor, had no significant effect on [Ca2+](i), but it completely inhibited MLC phosphorylation and partially inhibited tension. The wortmannin-resistant tension development was thus not associated with MLC phosphorylation, and this component was completely inhibited by Y27632. 4 In conclusion, U46619 enhanced Ca2+ sensitivity in a manner both dependent and independent of MLC phosphorylation in the bovine middle cerebral artery. Both mechanisms of Ca2+ sensitization can be inhibited by the Rho-kinase inhibitor.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available